Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein

Clinica Chimica Acta

Volumn 382, Issue 1-2, 2007, Pages 31-36

  Tzang, Bor Show ^a   Lee, Yi Ju ^a   Yang, Tzi Peng ^a   Tsay, Gregory J ^a,b   Shi, Jing Yu ^a   Tsai, Chun Chou ^a   Hsu, Tsai Ching ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anti beta2 glycoprotein I antibody (anti 2GPI); Anti phospholipid antibody (APhL); Anti phospholipid syndrome (APS); Human parvovirus B19 (B19); VP1 unique region protein (VP1u)

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; PHOSPHOLIPID ANTIBODY; PROTEIN VP1; RABBIT ANTISERUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; FEMALE; IMMUNOBLOTTING; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN INDUCTION; RABBIT; STATISTICAL ANALYSIS;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; AUTOIMMUNITY; CAPSID PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; MICE; MICE, INBRED BALB C; PARVOVIRUS B19, HUMAN; RABBITS;

MUS; ORYCTOLAGUS CUNICULUS; PARVOVIRUS;

EID: 34249060289     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.03.014     Document Type: Article

References (37)

1. Corcoran A., and Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 53 (2004) 459-475
2. Young N.S., and Brown K.E. Parvovirus B19. N Engl J Med 350 (2004) 586-597
3. Rayment F.B., Crosdale E., Morris D.J., et al. The production of human parvovirus capsid proteins in Escherichia coli and their potential as diagnostic antigens. J Gen Virol 71 (1990) 2665-2672
4. Modrow S., and Dorsch S. Antibody responses in parvovirus B19 infected patients. Pathol Biol (Paris) 50 (2002) 326-331
5. Schwarz T.F., Roggendorf M., and Deinhardt F. Human parvovirus B19: ELISA and immunoblot assays. J Virol Methods 20 (1988) 155-168
6. Kurtzman G.J., Cohen B.J., Field A.M., et al. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 84 (1989) 1114-1123
7. Anderson S., Momoeda M., Kawase M., Kajigaya S., and Young N.S. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. Virology 206 (1995) 626-632
8. Rosenfield S.J., Yoshimoto K., Kajigaya S., et al. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest 89 (1992) 2023-2029
9. Kawase M., Momoeda M., Young N.S., and Kajigava S. Most of the VP1 unique region of B19 parvovirus is on the capsid surface. Virology 211 (1995) 359-366
10. Musiani M., Manaresi E., Gallinelal G., et al. Immunoreactivity against linear epitopes of parvovirus B19 structural proteins. Immunodominance of the amino-terminal half of the unique region of VP1. J Med Virol 60 (2000) 347-352
11. Zadori Z., Szelei J., Lacoste M.C., et al. A viral phospholipase A2 is equired for parvovirus infectivity. Dev Cell 1 (2001) 291-302
12. Dorsch S., Leibisch G., Kaufmann B., et al. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 76 (2002) 2014-2018
13. Canaan S., Zadori Z., Ghomashchi F., et al. Interfacial enzymology of parvovirus phospholipases A2. J Biol Chem 279 (2004) 14502-14508
14. Lu J., Zhi N., Wong S., and Brown K.F. Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J Infect Dis 193 (2006) 582-590
15. Loizou S., Cazabon J.K., Walport M.J., Tait D., and So A.K. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 40 (1997) 103-108
16. Lunardi C., Tiso M., Borgato L., et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol 28 (1998) 936-948
17. Chou T.N., Hsu T.C., Chen R.M., Lin L.I., and Tsay G.J. Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL). Lupus 9 (2000) 551-554
18. von Landenberg P., Lehmann H.W., Knoll A., et al. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 48 (2003) 1939-1947
19. Hsu T.C., and Tsay G.J. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology (Oxford) 40 (2001) 152-157
20. Lehmann H.W., von Landenberg P., and Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2 (2003) 218-223
21. Meyer O. Parvovirus B19 and autoimmune diseases. Joint Bone Spine 70 (2003) 6-11
22. Landenberg P., and Modrow S. Human parvovirus B19 infection and antiphospholipid-syndrome: the two sides of one medal?. J Vet Med B Infect Dis Vet Public Health 52 (2005) 353-355
23. Tzang B.S., Tsay G.J., Lee Y.J., Li C., Sun Y.S., and Hsu T.C. The association of VP1 unique region protein in acute parvovirus B19 infection and antiphospholipid antibody production. Clin Chim Acta 378 (2007) 59-65
24. Hsu T.C., Wu W.J., Chen M.C., and Tsay G.J. Human parvovirus B19 nonstructural protein (NS1) induces apoptosis through mitochondria cell death pathway in monkey epithelial COS-7 cells. Scand J Infect Dis 36 (2004) 570-577
25. Rubin R.L., Joslin F.G., and Tan E.M. An improved ELISA for anti-native DNA by elimination of interference by anti-histone antibodies. J Immunol Methods 63 (1983) 359-366
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-684
27. Towbin H., Stachelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamid gels to nitrocellulose sheet: procedure and some applications. Proc Natl Acad Sci U S A 76 (1979) 4350-4354
28. Blank M., Cohen J., Toder V., and Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 88 (1991) 3069-3073
29. Blank M., and Shoenfeld Y. Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations. Clin Immunol 112 (2004) 190-199
30. Lim W., Crowther M.A., and Eikelboom J.W. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295 (2006) 1050-1057
31. Shoenfeld Y., Blank M., Cervera R., Font J., Raschi E., and Meroni P.L. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 65 (2006) 2-6
32. Harel M., Aron-Maor A., Sherer Y., Blank M., and Shoenfeld Y. The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. Immunobiology 210 (2005) 743-747
33. Gharavi E.E., Chaimovich H., Cucurull E., et al. Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides. Lupus 8 (1999) 449-455
34. Zhang J., and McCrae K.R. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2-glycoprotein I antibodies. Blood 105 (2005) 1964-1969
35. Raschi E., Testoni C., Bosisio D., et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 101 (2003) 3495-3500
36. Asherson R.A., and Cervera R. Antiphospholipid antibodies and infections. Ann Rheum Dis 62 (2003) 388-393
37. Pierangeli S.S., and Harris E.N. Clinical laboratory testing for the antiphospholipid syndrome. Clin Chim Acta 357 (2005) 17-33